Eledon Pharmaceuticals, Inc. — Form D

Eledon Pharmaceuticals, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-23. $50.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
David-Alexandre GrosDirectorIrvine, CA
Jan HillsonDirectorIrvine, CA
Keith KatkinDirectorIrvine, CA
Allan KirkDirectorIrvine, CA
June LeeDirectorBerkeley, CA
John McBrideDirectorToronto, A6
Walter OgierDirectorIrvine, CA
Steven PerrinDirectorIrvine, CA
James RobinsonDirectorMorrisville, NC
David-Alexandre GrosExecutive OfficerIrvine, CA
Paul LittleExecutive OfficerPine Ridge, SD
Steven PerrinExecutive OfficerIrvine, CA
Bryan SmithExecutive OfficerNew York, NY
Erez ChimovitsDirectorNESS ZIONA, L3
David KesslerDirectorTROY, MI
CATHERINE TURKELExecutive OfficerKelowna, A1
Keith A KatkinDirectorSan Diego, CA
Reinhard J AmbrosDirectorWaltham, MA
Cheryl CohenDirectorSan Diego, CA
Gary LyonsDirectorIrvine, CA
Gregory FlesherDirectorSan Diego, CA
Gregory FlesherExecutive OfficerSan Diego, CA
John A McBrideDirectorIrvine, CA
Steven N PerrinDirectorIrvine, CA
Gary A LyonsDirectorIrvine, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-05-22D$35.0M
2020-09-25D$108.1M$108.1M
2020-01-27D$5.8M$862K
2019-05-10D$28.5M$862K
2013-05-15D$35.5M$20.0M
2011-09-20D$23.0M$1.9M
2009-05-06D$22.0M$10.0M

More